Recommended Topic Related To:

AdreView

"Nov. 4, 2014 -- Twenty-year-old Milton Wright III's life seemed to finally be on track. After a lifetime of interruptions to his education, his football career, and his plans to join the Marines, he found his way. He had launched a modeling caree"...

AdreView

PATIENT INFORMATION

Instruct patients to inform their physician or healthcare provider if they:

  1. are pregnant or breast feeding.
  2. are sensitive to iodine, an iodine-containing contrast agent or other products that contain iodine.
  3. are sensitive to Potassium Iodide Oral Solution, or Lugol's Solution.
  4. have reduced renal function.

Instruct patients to increase their level of hydration prior to receiving AdreView (iobenguane i 123 injection for intravenous use) and to void frequently for the first 48 hours following AdreView (iobenguane i 123 injection for intravenous use) administration.

Last reviewed on RxList: 10/2/2009
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.